Inlyta
Inlyta is an originator product from Pfizer AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 304.65 to CHF 2'898.55 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Pfizer AG
- ATC code
- L01EK01
- IT group
- 07.16.10 Cytostatica
- Active substances
- Axitinibum
- Preparation type
- Originator product
- On the SL since
- 01/06/2012
- Last price change
- 01/11/2025
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Filmtabl 1 mg | 28 Stk | CHF 269.87 | CHF 304.65 | 01/06/2012 | A | 7680622810015 |
| Filmtabl 1 mg | 56 Stk | CHF 539.74 | CHF 592.85 | 01/06/2012 | A | 7680622810022 |
| Filmtabl 3 mg | 28 Stk | CHF 809.61 | CHF 881.05 | 01/06/2014 | A | 7680622810053 |
| Filmtabl 5 mg | 28 Stk | CHF 1'349.35 | CHF 1'457.50 | 01/06/2012 | A | 7680622810039 |
| Filmtabl 5 mg | 56 Stk | CHF 2'698.70 | CHF 2'898.55 | 01/06/2012 | A | 7680622810046 |
| Filmtabl 7 mg | 28 Stk | CHF 1'889.09 | CHF 2'033.90 | 01/06/2014 | A | 7680622810077 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
More preparations in this group
FAQ
Is Inlyta covered by Swiss health insurance?
Yes, but only under conditions. Inlyta is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Inlyta cost in Switzerland?
The public price is the maximum price set by the FOPH and for Inlyta ranges from CHF 304.65 to CHF 2'898.55 per pack. The ex-factory price ranges from CHF 269.87 to CHF 2'698.70. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages